Letters to the Editor
Labels for prescription medicines
- Ashok Chotai
- Aust Prescr 1 2018;41:101
- 1 August 2018
- DOI: 10.18773/austprescr.2018.037
Thank you for the article on safer dispensing labels.1 A patient-centric label should have the generic name in bold and prominently printed and the brand name in less prominent print. This should improve patient recognition of medications, and avoid duplications of different brand names often dispensed by pharmacists.
The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by any responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.